This information was provided by prnewswire
Send your Press Release here.
TSX:IN
OTCQX:IMLFF
VANCOUVER, Jan. 3, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX : IN) (OTCQX : IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, will be presenting at the Biotech Showcase 2019 on Wednesday, January 9, 2019, at 9:00 AM PT / 12:00 PM ET at the Hilton San Francisco Union Square, in San Francisco, California.
A live audio webcast of the presentation will be available through InMed’s corporate website in the ‘Investor’ section at https://investors.inmedpharma.
Leave a Reply